Atlas Trials

Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia

Clinical trial NCT00244231 · COMPLETED

Trial details

NCT number
NCT00244231
Sponsor
Genovate Biotechnology Co., Ltd.,
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperlipidemia
Start date
2003-10-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.